Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
18.58%Free Cash Flow Margin
VS
Market
Sector
Industry
History
$ 5.47Close
$ 2.42 - $ 5.73 52-Week Range
Ticker Information
Ticker
PBYICompany Name
PUMA BIOTECHNOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPUMA BIOTECHNOLOGY INC - Free Cash Flow Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PBYI - FCF % Historical data
| Date | Free Cash Flow | Free Cash Flow Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 44.22M | 18.58% | $ 238.06M |
| 3/31/2025 | $ 31.17M | 13.39% | $ 232.71M |
| 12/31/2024 | $ 38.86M | 16.86% | $ 230.47M |
| 9/30/2024 | $ 33.68M | 13.83% | $ 243.57M |
| 6/30/2024 | $ 33.25M | 15.17% | $ 219.14M |
| 3/31/2024 | $ 35.47M | 15.65% | $ 226.63M |
| 12/31/2023 | $ 26.87M | 11.4% | $ 235.64M |
| 9/30/2023 | $ 24.14M | 10.54% | $ 229.13M |
| 6/30/2023 | $ 30.81M | 13.39% | $ 230.12M |
| 3/31/2023 | $ 13.71M | 5.83% | $ 235.07M |
Key Performance Insights, Last 5 Years
- PUMA BIOTECHNOLOGY INC's latest trailing twelve months (TTM) FCF % stands at 3.25%.
- Over the past 5 years, PUMA BIOTECHNOLOGY INC's average FCF % has been 6.05%.
- The median FCF % for PUMA BIOTECHNOLOGY INC during this period was 9.21%
- PUMA BIOTECHNOLOGY INC reached its highest FCF % over the past 5 years at 18.58%.
- The lowest FCF % recorded by PUMA BIOTECHNOLOGY INC in the same timeframe -17.26%
PUMA BIOTECHNOLOGY INC's FCF % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF % Benchmarks
Similar metrics to Revenues:
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
Definition of Free Cash Flow Margin
[Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.FCF / Revenues
(=) FCF % FCF % for PUMA BIOTECHNOLOGY INC is calculated as follows: FCF [ $ 7.64M ] / Revenues [ $ 235.47M ]
(=) FCF % [ 3.25% ] PBYI - Free Cash Flow Margin, Last 5 years
-17.26%
Minimum
Jun 30, 2022
18.58%
Maximum
Jun 30, 2025
6.05%
Average
9.21%
Median
FCF % Benchmark AnalysisMarket
The chart above depicts the distribution of FCF % for companies in the Total Stock Market. The average FCF % of the companies is 7.85% with a standard deviation of 19.48%.
The following table provides additional summary stats:
FCF % in the Market:
| filtered constituents | 3.18K |
|---|---|
| min | -58.23% |
| max | 68.19% |
| average | 7.85% |
| median | 7.37% |
| std | 19.48% |